About
“There’s no more noble cause than pursuit of human health and happiness for all.”
Dr. Scott Tackett
CEO & President, 2025
Our mission
Earlier detection only matters if people can access it.
At AIRA Sciences, we believe multi-cancer screening and detection should be accurate, non-invasive, simple, accessible and affordable.
So people can live life fully.
Leadership
Who leads the company.
Dr. Scott Tackett
Chief Executive Officer & President
A health economist and healthcare strategist whose work centers on implementation science — the question of why proven evidence takes so long to reach everyday clinical practice, and what has to change for it to arrive sooner.
Dr. Liberty Foreman
Founder, Chief Innovation Officer & Chair of the Board
Founded the science behind AIR-DS and leads the company’s product and platform roadmap and its long-term direction, working on infrared spectroscopy applied to earlier cancer detection.
Our story
How AIRA Sciences began.
Collaboration
How we work with others.
Earlier detection depends on people and organizations across the journey. We welcome conversations in each of these areas.
Health systems
Implementation and delivery within real clinical services.
Clinical research
Evidence generation alongside clinical partners.
Scientific research
Collaboration on the underlying science.
Patient organizations
Working with advocacy and community groups.
Advancing infrared applications for earlier detection — beginning with lung cancer.
AIR-DS is a UKCA marked in vitro diagnostic medical device, developed in accordance with IEC 62304 and under an ISO 13485 certified quality management system. In the US, a CLIA certified laboratory will offer a laboratory developed test (LDT) with AIR-DS Lung Test. It has not been cleared or approved by the FDA. Information on this website is provided for educational and informational purposes and should not be interpreted as medical advice.